Springleaf Initiative logo: a green leaf inside a circle with the words Steal A Chance

Home › Medical Options › NK Cell Immunotherapy

NK Cell Immunotherapy vs. Chemotherapy

— Steal a chance to understand your options

Natural Killer (NK) cell immunotherapy and conventional chemotherapy represent two fundamentally different approaches to treating cancer. While chemotherapy relies on chemical compounds to destroy rapidly dividing cells, NK cell therapy harnesses or enhances the body's innate immune system to recognize and kill cancer cells.

Key differences at a glance

FeatureConventional ChemotherapyNK Cell Immunotherapy
MechanismCytotoxic drugs target rapidly dividing cells.Infused or activated NK cells target cancer cells via innate molecular signals.
SpecificityNon-specific; affects healthy fast-dividing cells (hair, gut, blood).Targeted/Selective; recognizes stressed or tumor cells while sparing normal tissue.
Treatment DeliveryIntravenous (IV) or oral chemical regimens given in cycles.Cell infusion (autologous, allogeneic donor, or off-the-shelf engineered CAR-NK cells).
Primary IndicationBroadly used across frontline cancer treatments, regimens, and shrinking bulk tumors.Refractory/relapsed hematologic cancers, adjuvant therapy, or emerging clinical trials.
Side EffectsAlopecia, severe nausea, systemic toxicity, bone marrow suppression.Mild fever/chills, transient immune reaction (significantly lower risk of CRS or GvHD).

Detailed comparison

Mechanism of action

Chemotherapy

Disrupts DNA replication or cell division pathways. Because cancer cells divide rapidly, they are disproportionately killed, but healthy fast-dividing tissues are also damaged.

NK cell therapy

Uses innate immune cells that recognize tumor cells through a balance of activating and inhibitory receptors. NK cells detect cells with missing HLA/MHC-I markers (“missing-self” hypothesis) or stress signals, destroying them via perforin and granzymes without needing prior antigen exposure.

Side effect profile

Chemotherapy

Causes systemic toxicities due to off-target cell death. Typical side effects include hair loss, mucosal damage (mouth sores/diarrhea), severe fatigue, and increased risk of infection from neutropenia.

NK cell therapy

Generally far better tolerated. Unlike T-cell therapies (e.g., CAR-T), NK cells carry a minimal risk of Severe Cytokine Release Syndrome (CRS), neurotoxicity, or Graft-versus-Host Disease (GvHD), making allogeneic (“off-the-shelf”) donor infusions safer.

Response duration & memory

Chemotherapy

Effective at quickly reducing tumor burden, but once the drugs clear, resistant cancer cells can trigger a relapse.

NK cell therapy

Offers potential for long-lasting responses. Activated NK cells can clear residual micro-metastases and recruit broader immune responses to prevent recurrence.

How they work together

Rather than viewing them strictly as competitors, modern oncology frequently combines them.

1

Debulking

Chemotherapy can quickly shrink massive tumor loads.

2

Immune conditioning

Low-dose chemotherapy helps deplete suppressive regulatory cells, creating a favorable environment before NK cell infusion.

3

Eradication

NK cells target remaining chemo-resistant cancer stem cells and circulating tumor cells to minimize relapse risk.

This page is for general information only and is not medical advice. Which treatment is suitable depends on the type and stage of cancer and on your overall health; please discuss all options with your oncologist.

Get in touch

Steal a chance by talking to us

Share with us your thoughts, your questions, or simply where you are today. Tell us how we can support your journey, and we will get back to you.

Prefer email? Write to enquire@springleaf.asia
We help with non-clinical arrangements only. Please do not send medical records or detailed health information through this form. We will tell you how to share documents safely.

Your details are used only to respond to your enquiry.